Warfarin Increases Stroke Risk in Atrial Fibrillation Patients

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A study published in the European Heart Journal finds that atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy. Data on stroke incidence in patients newly diagnosed with atrial fibrillation was analyzed and each case of stroke was randomly matched with 10 controls. Stroke risk was significantly higher among patients who had begun taking warfarin within 30 days when compared with patients who had not used any antithrombotic therapy for at least 1 year. Patients taking warfarin had a lower risk for stroke when they had been taking the drug longer than 1 month.

To read the full article on HCPLive.com, click here.
Related Articles
The JNC 8 guidelines are based on 27 large clinical trials that are often discussed in isolation, but have never been aggregated into a single source until now.
A new cardiovascular risk estimator can accurately predict heart disease and stroke risk for anyone in the world aged 40 years or older.
While the FDA only recommends daily aspirin for patients who have experienced major cardiovascular events, about half of older adults in the United States take aspirin regularly.
Pharmacist-driven drug management programs best ensure atrial fibrillation patients adhere to the warfarin alternative, dabigatran (Pradaxa).
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$